Displaying 1751-1800 of 2252 result(s).
Recent Articles
- Coinbase's Q4 Earnings Reveal Growth and Ambitious Future Plans
- Heron Therapeutics Announces Upcoming Financial Results Call
- Pangaea Logistics Solutions Ltd. Declares Cash Dividend Payable
- Pond Technologies Welcomes New Leadership Post CFO Transition
- Aker Carbon Capture ASA Announces Upcoming General Meeting
- ISS Endorses Payfare's Agreement with Fiserv for Shareholders
- Island Passage Exploration Sets Ambitious Goals for 2025
- Applied Materials Delivers Impressive Q1 2025 Financial Results
- Airbnb's Q4 and Full Year 2024 Financial Performance Unveiled
- iPower Inc's Positive Revenue Growth in Q2 2025 Highlights
- PacBio's Q4 and Year-End 2024 Results: Challenges and Innovations
- Waystar Sets Industry Standard in AI-Powered Healthcare Solutions
- ATI Launches Advanced Facility for Additive Manufacturing Success
- Aker Carbon Capture ASA Hosts Virtual Extraordinary Meeting
- Key Insights on Aker Carbon Capture ASA's Upcoming Meeting
- Tevogen Bio Applauds New HHS Secretary, Reinforces Health Goals
- Rocket Companies Set to Reveal Annual Results February 27
- NeuroPace Pursues $65 Million Public Offering to Enhance Growth
- Outset Medical Successfully Resolves FDA Warning Letter Issues
- Pangaea Logistics Solutions Declares Cash Dividend for Shareholders
- PG&E's Strategic Expansion to Meet Growing Data Center Energy Demand
- Walter G. Bumphus Reflects on a Distinguished AACC Career
- Elanco Animal Health Elevates Focus on Pet Care Education
- Ameren Corporation Projects Steady Growth and Earnings
- MDU Resources Group Declares Consistent Dividend Payment
- Paramount Global Set to Unveil Impressive Year-End Results
- UMKC Achieves Carnegie R1 Status: A Benchmark for Research Excellence
- Western Copper and Gold Updates on Casino Project Metallurgy
- Credit Acceptance's Planned Redemption of Senior Notes Explained
- Cooper Standard Reports Growing Income and Strong Cash Flow
- Travere Therapeutics Financial Results Announcement Insights
- ICU Medical's Voluntary Recall of Misbranded Potassium Chloride
- Esperion's RSU Grants: A Strategic Initiative for Growth
- Neptune Flood Research Highlights Path to Private Insurance Transition
- Aureus Greenway Holdings Successfully Completes IPO Process
- GCL and RF Acquisition Corp. Celebrate Significant Nasdaq Listing
- Aptose Biosciences Secures $25 Million through Equity Financing
- Actelis Networks Welcomes Industry Veteran Julie Kunstler
- Precision Optics Achieves Remarkable Growth in Q2 Financials
- Shattuck Labs to Present Innovative Antibody Research at ECCO
- Upcoming GoHealth Q4 2024 Results and Future Outlook
- Allogene Therapeutics Showcases Promising CAR T Data in Lymphoma
- Cenovus Energy Prepares to Share Q4 and Year-End Results
- Orrstown Financial Services Appoints Adam Metz as COO
- Impressive Growth Journey: DraftKings Financial Year Insights
- ConnectM Upgrades Q4 '24 Revenue Projections to $9 Million
- Piedmont Office Realty Trust's Impressive 2024 Financial Performance
- GoDaddy Celebrates Remarkable Growth in 2024 Financials
- Patria Adjusts Record Date for Quarterly Dividend Payment
- Elme Communities Reports Year-End and Q4 Results for 2024